Clinical Trials Logo

Neurologic Deficits clinical trials

View clinical trials related to Neurologic Deficits.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT05075382 Withdrawn - Elbow Fracture Clinical Trials

Fracture and Neurological Injury

FIRE
Start date: July 1, 2022
Phase:
Study type: Observational

The goal of the project is to describe novel factors affecting outcome after elbow fracture surgery with an in-depth evaluation of the role played by neuro inflammation from concomitant peripheral nerve injury or head injury in elbow fracture outcomes. Among all upper limb fractures, elbow trauma is the most frequently associated with a severe impact on patient function and quality of life. One of the main reasons for poor outcomes is the complexity of the elbow joint, which involves three bones and two planes of motion, essential to position the hand in space. The flexion extension axis is crucial for eating and hygiene, while forearm pro-supination is mandatory for most professions, from office work to manual labour.

NCT ID: NCT02999945 Withdrawn - Diabetes Clinical Trials

Optimal Growth of Preterm Infants With Growth Restriction

OPTIGROW
Start date: March 2019
Phase: N/A
Study type: Interventional

In this prospective randomized controlled multi center trial the investigators stratify "Very Low Birthweight " (VLBW)-infants with growth retardation in small for gestational age (SGA) or intrauterine growth restricted (IUGR) - infants and aim to investigate the impact of a nutritional management with enhanced nutrients from discharge up to the 52nd week of postconceptional age on growth, body composition, metabolic programming, metabolomics, microbiome and long term neurodevelopmental outcome. In this study, the investigators will evaluate the difference in metabolic profiles of SGA and IUGR preterm infants. The investigators will further longitudinally assess, how different nutritional interventions affect the altered pathways in the first year of life and identify, in combination with data available from metabolic markers, microbiome and breast milk analysis, potential pathways resulting in increased disease risk later in life.